We present a 52-year-old woman with Graves' disease, who was characterized by having both chronic thyrotoxic myopathy and posterolateral myelopathy. Both symptoms began and progressed concomitantly.
INTRODUCTION
Graves' disease is a multiorgan metabolic disorder with hyperthyroid state. It is well known that hyperthyroidism is associated with several neuromuscular disorders including acute thyrotoxic myopathy, chronic thyrotoxic myopathy, exophthalmic opthalmoplegia, myasthenia gravis and periodic paralysis1). We have recently experienced a patient with characteristic manifestations of myelopathy in addition to chronic thyrotoxic myopathy. Nagai, Tomizawa, Satou, Mori no significant abnormalities. Table 1 shows the values of thyroid functions with increase in free-T4 and free-T3 concentrations. Basal metabolic rate (BMR) was + 26%. The titers of antimicrosomal antibody and anti TSH receptor antibody were elevated. Antithyroid antibody was negative. Thyroid scintigram using 123I showed diffuse high uptake.
123I thyroid uptake was 49% at 3hrs and 35% at 24hrs.
These data were compatible with hyperthyroidism. Myogenic pattern consisting of low amplitude and short duration was shown by needle electromyography of quadriceps femoris muscles.
Conduction
velocities and latencies of bilateral median, ulnar and peroneal nerves were normal.
Roentgenograms of the entire spine, myelogram, magnetic resonance imaging and brain computed tomography showed no abnormalities.
Serum vitamin B12 and folic acid were within normal limits. Results of cerebrospinal fluid examination, including protein concen-tration, cell counts, serologic tests for syphilis, fluorescent treponemal antibody absorption tests, were normal. Microscopic examination of biopsy specimen from quadriceps femoris muscle showed almost normal findings. Edrophonium chloride injection caused no improvement in muscular weakness. The oral administration of methimazole was followed by progressive amelioration of muscle strength and laboratory data and weight gain. Electromyography of the quadriceps femoris muscle showed normal pattern 7 months after. However, the neurologic manifestations consisting of hyperreflexia, positive Babinski and Chaddock signs, and diminished vibration sense in the lower limbs with spastic gait, remained almost unchanged on follow-up examination for 3 years. ranged within normal. These observations suggested that hyperthyroidism may be responsible for the posterolateral myelopathy in this patient. The pathophysiological mechanisms by which hyperthyroidism caused myelopathy remain unknown at present, but one possibility is that both thyrotoxicosis and posterolateral myelopathy shared a common cause affecting the different organs simultaneously. In our patient the titer of antimicrosomal antibody and anti-TSH receptor antibody were elevated, and posterolateral myelopathy may be related to autoimmunity in its pathogenesis, this concept being proposed by Melamed et al4). Alternatively the other possibility is that thyrotoxicosis itself may directly cause myelopathy. Hyperthyroidism can cause varying metabolic abnormalities at many organs containing muscles and central nervous system. Mitochondrial abnormalities have been observed on electron microscopy in the muscle fibers of rats and humans with hyperthyroidism7). It has been reported that the cellular dysfunctions were due to a direct effect of excessive thyroid hormone which resulted in the rapid decline in mitochondrial respiration and oxidative phosphorylation8), and farther the intramuscular changes in water electrolytes and enzymes9). Concerning this problem it must be clarified how thyroid hormone physiologically and pathologically acts on nerve cellular functions in the present case.
DISCUSSION

